Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $60.05 USD
Change Today -1.53 / -2.48%
Volume 2.1M
ABBV On Other Exchanges
New York
EN Paris
As of 11:00 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for abbvie inc (ABBV)

AbbVie Inc. may have more financial risk than other companies in the Pharmaceuticals industry as it is one of the most highly leveraged with a Debt to Total Capital ratio of 89.60%. This ratio actually increased over the last year. However, an examination of near-term assets and liabilities shows that there are enough liquid assets to satisfy current obligations. Accounts Receivable are typical for the industry, with 57.83 days worth of sales outstanding. Last, inventory levels, relative to its Cost of Goods Sold, are typical for the industry and have shown a consistent decrease during the last 4 years. This implies that management is becoming more efficient.
Currency in
Millions of US Dollars
As of:Dec 31
Dec 31
Dec 31
Dec 31
4 Year
Cash and Equivalents27.05,901.09,595.08,348.0
Short-Term Investments626.02,075.0300.026.0
Accounts Receivable3,817.03,602.03,116.03,209.0
Other Receivables--696.01,687.01,082.0
TOTAL RECEIVABLES3,817.04,298.04,803.04,291.0
Prepaid Expenses504.01,305.01,217.01,192.0
Deferred Tax Assets, Current1,469.0669.0766.0896.0
Other Current Assets39.015.017.0211.0
TOTAL CURRENT ASSETS7,354.015,354.017,848.016,088.0
Gross Property Plant and Equipment5,948.06,542.06,909.07,105.0
Accumulated Depreciation-3,804.0-4,295.0-4,611.0-4,620.0
NET PROPERTY PLANT AND EQUIPMENT2,144.02,247.02,298.02,485.0
Long-Term Investments229.0119.0118.092.0
Other Intangibles2,910.02,323.01,890.01,513.0
Other Long-Term Assets784.0835.0767.01,507.0
TOTAL ASSETS19,521.027,008.029,198.027,547.0
Accounts Payable417.0556.0933.0881.0
Accrued Expenses1,972.02,139.02,022.02,007.0
Short-Term Borrowings--1,020.0413.0425.0
Current Portion of Long-Term Debt/Capital Lease16.022.018.04,021.0
Other Current Liabilities, Total3,492.03,039.03,493.04,066.0
TOTAL CURRENT LIABILITIES5,897.06,776.06,879.011,400.0
Long-Term Debt32.014,630.014,292.010,565.0
Pension & Other Post-Retirement Benefits397.0979.01,628.02,220.0
Deferred Tax Liability Non-Current646.0360.0570.0630.0
Other Non-Current Liabilities617.0900.01,337.0990.0
TOTAL LIABILITIES7,589.023,645.024,706.025,805.0
Common Stock11,957.03,713.016.016.0
Additional Paid in Capital----3,671.04,194.0
Retained Earnings----1,567.0535.0
Treasury Stock-----320.0-972.0
Comprehensive Income and Other-25.0-350.0-442.0-2,031.0
TOTAL COMMON EQUITY11,932.03,363.04,492.01,742.0
TOTAL EQUITY11,932.03,363.04,492.01,742.0
TOTAL LIABILITIES AND EQUITY19,521.027,008.029,198.027,547.0

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABBV:US $60.05 USD -1.53

ABBV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amgen Inc $147.27 USD -1.96
Bristol-Myers Squibb Co $57.92 USD -0.83
Eli Lilly & Co $80.82 USD -0.78
Medtronic PLC $68.30 USD -1.68
Novo Nordisk A/S kr364.80 DKK -8.60
View Industry Companies

Industry Analysis


Industry Average

Valuation ABBV Industry Range
Price/Earnings 47.5x
Price/Sales 4.7x
Price/Book 18.3x
Price/Cash Flow 48.4x
TEV/Sales 2.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABBVIE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at